DEPLOYDatabase

Deployment

Versius at India

CMR Surgical (founded 2014, Cambridge, UK; private) makes Versius, the genuine challenger among surgical-robot startups and the one that has clearly crossed the regulatory gating event. Versius is a modular multi-arm teleoperated soft-tissue robot that is heavily software-driven, capturing telematic, video, and outcome data. It received US FDA De Novo marketing authorization in October 2024, the first such authorization for a multi-port soft-tissue general-surgery robot, followed by an FDA 510(k) clearance for the next-generation Versius Plus on December 18, 2025 with US commercialization on track for 2026, and a pending gynecology 510(k) submitted on April 29, 2026; it has long been CE-marked and commercial across Europe, Latin America, the Africa-Middle-East region, and Australia, with more than 40,000 procedures completed outside the US by company reporting.

The registry records it at commercial maturity with an active lifecycle. An important current-state correction: the 2021 roughly $3 billion SoftBank-led valuation story is frozen in time, the company went through real restructuring in 2023 with about 350 redundancies, and it was recapitalized with more than $200 million in April 2025, while reported figures of a roughly $3.1 billion 2025 valuation and a potential $4 billion sale are rumor-tier aggregator claims that are not registered.

On AI substance the shipped reality is a data-capture and analytics ecosystem with the surgeon in full control; the physical-AI framing is forward-looking, anchored in a March 2026 NVIDIA IGX Thor partnership to evaluate AI for a future Versius, with no autonomous or AI-assisted intraoperative feature cleared or shipped.

Versius by CMR Surgical · Catalog entry · 6 sources · not yet field-verified · Surgical robots

Track Versius at India

Recent coverage

See all coverage →

Versius has been installed across approximately 10 or more hospitals in India, including Apollo and Aster facilities, following CDSCO approval for laparoscopic surgery. AIMS Faridabad is among the sites that introduced the Versius robotic surgical system.

Key facts

India sites
~10+ hospitals (Apollo, Aster, others)
CDSCO approval
Approved for laparoscopic surgery

Exposure

Customer segment
healthcare
Scale tier
commercial 10 99

Each exposure value carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Safety record

1 recall and 4 incidents on record (1 serious, 1 moderate, 3 minor). Most recent: Jul 2026.

serious
1
moderate
1
minor
3
regulatory action
3
recall
1
malfunction
1

Most recent: Jul 2026

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Incidents on record (5)

Direct incidents recorded against this deployment. Retracted incidents are excluded here but remain reachable at their canonical URLs.

Trust tier
Catalog entry · 6 sources · not yet field-verifiedhow tiers work →
Last updated
2026-08-21
Model
Versius
Company
CMR Surgical
Location
India
Operator
CMR Surgical
Status
operational
Operator type
maker operated
Scale at site
11 to 100 units
Site environment
indoor
Location precision
verified coordinates
First seen
2022-01-01
ID
1d0a5255-5897-4f31-8d4f-aabcb83529a1

Timeline

  1. Jan 2022
    First recorded
    Versius first documented operating at India.
  2. Jan 2022
    created
  3. Aug 2026
    Current status: operational, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Free to use on your site, with a link back to DEPLOY.

Versius operates in India. Explore the full verified map:

Sources (6)

  1. https://cmrsurgical.com/news/cmrsurgical-announces-first-versius-installations-in-india/
  2. https://www.thehindu.com/sci-tech/health/versius-robotic-surgery-india/article67890123.ece
  3. https://www.expresshealthcare.in/news/aims-introduces-versius-robotic-surgical-system/437699/
  4. https://cmrsurgical.com/news/over-20000-surgical-cases-completed-using-versius
  5. https://cmrsurgical.com/news/cmr-surgical-india-middle-east-business-update
  6. https://robochronicle.com/can-surgical-robots-move-downmarket-cmr-surgicals-versius-test-in-india-and-the-economics-of-smaller-hospitals/
Methodology: Verified · 6 sources (no primary) · last reviewed 2026-08-21

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-21

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

6
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Versius at India.

Common questions

What is the Versius deployment at India?
Versius, built by CMR Surgical, is recorded as a deployment at India on the DEPLOY registry. CMR Surgical operates the deployment directly.
Who operates Versius at India?
CMR Surgical, the manufacturer of Versius, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
When did the Versius deployment at India go live?
The deployment is recorded as starting January 1, 2022 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
Have there been incidents at the Versius deployment at India?
5 active incidents affecting this deployment are on the DEPLOY registry. Each is a sourced, append-only record; retracted incidents are suppressed from this view.
Is Versius at India safe?
Versius at India has 5 active incidents on record in the DEPLOY registry. 1 recall and 4 incidents on record (1 serious, 1 moderate, 3 minor). Most recent: Jul 2026. Retracted incidents are excluded from this count.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.

Machine-readable surfaces